CRSP

NASDAQ 已收盘

CRISPR Therapeutics AG

38.93 USD
▼-1.26-3.14%
盘后 39.18 +0.64%
2026-11-19
市值
$3.85B
市盈率
—
EPS
-4.75
股息率
—
52 周区间
38.37 – 63.45
成交量
4.10M
Beta
1.90
目标价
85.42
52W 低 38.3752W 高 63.45
价格走势

公司简介

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. The company’s CRISPR/Cas9 is a technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, CAR T cell therapies, in vivo, and type 1 diabetes, as well as deve...